Vasculitis involves inflammation of the walls of blood vessels — arteries, veins, or capillaries — which can restrict blood flow and damage organs throughout the body. There are many forms: some affect only the skin, while others involve the kidneys, lungs, nerves, or brain. ANCA-associated vasculitis (GPA, MPA, EGPA) and giant cell arteritis are among the most serious forms. Without prompt diagnosis and treatment, vasculitis can cause irreversible organ damage or be life-threatening. Correct classification is essential because different subtypes require different treatment strategies. Dr. Kakar has extensive experience managing rare vasculitic syndromes and has published on ANCA-negative vasculitis and related conditions.
What is vasculitis?
When should you seek care?
How Dr. Kakar approaches treatment.
Diagnosis involves ANCA blood tests, imaging, and often tissue biopsy to classify the vasculitis type. Treatment is guided by disease type and severity — corticosteroids are used acutely, with cyclophosphamide, rituximab, methotrexate, or azathioprine for maintenance. Newer biologic agents are available for refractory disease. Monitoring for relapse and medication side effects is a critical part of long-term management.
When to see a specialist.
Seek specialist review urgently if you have a combination of rash, joint pain, fever, and signs of kidney or lung involvement. Giant cell arteritis requires emergency evaluation if you experience sudden visual changes or jaw pain. Early treatment prevents permanent damage.